abstract |
The present invention provides novel substituted 3- (2,5-disubstituted) pyridyl-4-aryls useful for treating diseases that are ameliorated by reducing TNF-α production and / or p38 activity in appropriate cells. Pyrrole and a pharmaceutical composition containing the same are provided. The present invention also provides methods of treatment and prevention using the present pharmaceutical composition. |